Here are relevant reports on : single-molecule-imaging-market
-
Single-use Bioreactors Market by Product (Systems, Bags, Assemblies), Type (Stirred Tank, Bubble-Column, Wave induced), Molecule (mAbs, Vaccines), Cell Type (Mammalian, Bacterial, Yeast), Application (R&D, Bioproduction) - Global Forecast to 2029
The global single-use bioreactors market, valued at US$4.1 billion in 2023, stood at US$4.4 billion in 2024 and is projected to advance at a resilient CAGR of 15.4% from 2024 to 2029, culminating in a forecasted valuation of US$9.1 billion by the end of the period. Advantages over conventional bioreactors, lower capital investment, reduced water and energy usage, the expanding biologics and biosimilars markets, and increased adoption among CDMOs, CMOs, and SMEs are some of the factors driving market growth.
- Published: August 2024
- Price: $ 4950
- TOC Available:
-
Single-molecule Real-time (SMRT) Sequencing Market by Offering (Products, Services), Workflow (Sequencing, Data Analysis), Application (Drug Discovery, Diagnostic, Agriculture), End User (Academia, Pharma, Biotech) - Forecast to 2030
The Single-molecule Real-time (SMRT) Sequencing Market, valued at US$2.83 billion in 2024, stood at US$2.92 billion in 2025 and is projected to advance at a resilient CAGR of 12.8% from 2025 to 2030, culminating in a forecasted valuation of US$5.32 billion by the end of the period. This market is expanding as long-read sequencing is used more often in rare disease diagnostics, cancer genomics, and broader precision medicine programs.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Antibody Discovery Services Market by Type (Target Identification, Antibody Engineering (Technology (Hybridoma, Phage Display, Single Cell)), Immunization), Host (Mouse, Rat, Rabbit, Chicken, Camelids), Molecule (Monoclonal) - Global Forecast to 2030
The global antibody discovery services market, valued at US$1.68 billion in 2024, stood at US$1.90 billion in 2025 and is projected to advance at a resilient CAGR of 13.3% from 2025 to 2030, culminating in a forecasted valuation of US$3.54 billion by the end of the period. Key factors driving the antibody discovery services market include the advancement of formats such as bispecific antibodies (bsAbs) and antibody-drug conjugates (ADCs), coupled with increased venture funding and collaborative initiatives.
- Published: September 2025
- Price: $ 4950
- TOC Available:
-
GLP-1 Agonists Market by Product (Ozempic, Wegovy, Mounjaro), Molecule (semaglutide, tirzepatide), Type (Patented, Biosimilars), Format (Single dose, Multi-dose, Tablets), ROA (SC, Oral), Indication (Diabetes, Obesity) - Global Forecast to 2033
The global GLP-1 analogues market, valued at US$53.74 billion in 2024, stood at US$64.42 billion in 2025 and is projected to advance at a resilient CAGR of 13.0% from 2025 to 2033, culminating in a forecasted valuation of US$170.75 billion by the end of the period. The market for GLP-1 agonists is highly consolidated, with key players strategizing to capture the market. Prominent players in the GLP-1 agonists market are Novo Nordisk (Denmark), Eli Lilly (US), and Sanofi (France), among other players.
- Published: October 2025
- Price: $ 4950
- TOC Available:
-
Single-use Bioprocessing Market by Product (Equipment [Bioreactors, Filtration, Chromatography], Consumables [Filters, Bags, Assemblies, Sensors]), Application (Storage, Mixing), Workflow (Upstream), Molecule Type (mAbs, Vaccines) - Global Forecast to 2030
The global single-use bioprocessing market, valued at US$16.51 billion in 2024, stood at US$18.01 billion in 2025 and is projected to advance at a resilient CAGR of 13.3% from 2024 to 2030, culminating in a forecasted valuation of US$33.67 billion by the end of the period. The single-use bioprocessing market is witnessing significant expansion due to the increasing adoption of disposable technologies in the biopharmaceutical sector.
- Published: October 2025
- Price: $ 7150
- TOC Available:
-
Veterinary Imaging Market by Product (CT, MRI, Imaging Systems, Imaging Reagents, Imaging Software, Accessories), Animal Type (Small, Large), Application (Oncology, Dentistry), Modality (Portable, Stationary), End User, Region - Global Forecast to 2031
The global veterinary imaging market, valued at US$2.13 billion in 2025, stood at US$2.29 billion in 2026 and is projected to advance at a resilient CAGR of 7.7% from 2026 to 2031, culminating in a forecasted valuation of US$3.33 billion by the end of the period. This growth is driven by several factors, including an increase in pet ownership, rising spending on animal healthcare, a growing demand for early and accurate diagnosis, and advancements in imaging technologies such as digital radiography, ultrasound, computed tomography (CT), and magnetic resonance imaging (MRI).
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
Dental Imaging Market by Product (Extraoral Imaging (CBCT, Panoramic), Intraoral Imaging (X-ray, Intraoral Camera, IOL Scanner)), Application (Endodontics, Implantology), & End User (Dental Hospitals, Dental Diagnostic Centers) - Global Forecast to 2030
The global dental imaging market, valued at US$3.08 billion in 2024, stood at US$3.26 billion in 2025 and is projected to advance at a resilient CAGR of 7.5% from 2025 to 2030, culminating in a forecasted valuation of US$4.69 billion by the end of the period. The prominent players in the dental imaging market include Envista Holdings Corporation (US), Planmeca Oy (Finland), ACTEON (UK), DENTSPLY SIRONA Inc. (US), Carestream Dental LLC (US), VATECH (South Korea), Owandy Radiology, Inc. (France), DÜRR DENTAL AG (Germany), Midmark Corporation (US), Genoray Co., Ltd. (South Korea), Asahi Roentgen Co., Ltd. (Japan), 3Shape (Denmark), PreXion, Inc. (US), Ningbo Runyes Medical Instrument Co. Ltd.(China), Cefla Medical Equipment (Italy), Apteryx Imaging (Canada), Yoshida Dental Mfg. Co., Ltd. (Japan), Align Technology Inc. (US), J. MORITA CORP (Japan), and FONA Srl (Italy).
- Published: July 2025
- Price: $ 4950
- TOC Available:
-
Medical Imaging Workstations Market by Component (CPU, Hardware, Image Software), Modality (CT, MRI, Mammography), Application (Clinical Review, Diagnostic Imaging, 3D Imaging), Specialty, and Region - Global Forecasts to 2023
The medical imaging workstations market is projected to reach USD 1,377 million by 2023, growing at a CAGR of 8.9%. Factors such as the rising global burden of target diseases, increased product commercialization, rising public-private investments to support product development, evolving user preference for digital platforms, and the establishment of new medical facilities are driving the growth of the global medical imaging workstations market. General Electric Company (US), Koninklijke Philips N.V. (Netherlands), Siemens AG (Germany), Fujifilm Holdings Corporation (Japan), Canon Medical Systems Corporation (Japan), Carestream Health (US), Hologic (US), Carl Zeiss Meditec AG (Germany), Accuray Incorporated (US), Capsa Healthcare (US), Ampronix (US), Medicor Imaging (US), NGI Group (France), Alma IT Systems (Spain), and Pie Medical Imaging (Netherlands) are some of the major players operating in the global medical imaging workstations market.
- Published: January 2019
- Price: $ 4950
- TOC Available:
-
Preclinical Imaging Market by Product (Optical Imaging (Bioluminescence), Nuclear Imaging (PET, SPECT), MRI, Reagents (Luciferins, Infrared Dyes), Software), Application (Onco, Cardio), End User (Pharma, Biotech, Academic, CRO) - Global Forecast to 2030
The global preclinical imaging market, valued at US$3.36 billion in 2024, stood at US$3.53 billion in 2025 and is projected to advance at a resilient CAGR of 4.5% from 2024 to 2030, culminating in a forecasted valuation of US$4.39 billion by the end of the period.
- Published: December 2025
- Price: $ 4950
- TOC Available:
-
Breast Imaging Market by Technology (Ionizing, Non-ionizing), Product (Breast Imaging Systems, Software and Services, Accessories), End User (Hospitals and Clinics, Diagnostic Imaging Centers, Breast Care Centers) - Global Forecast to 2028
The global breast imaging market, valued at US$4.1 billion in 2022, stood at US$4.4 billion in 2023 and is projected to advance at a resilient CAGR of 8.5% from 2023 to 2028, culminating in a forecasted valuation of US$6.6 billion by the end of the period.The increasing number of research grants, rising focus on contrast-based diagnostic solutions, and rising awareness in developing economies are expected to drive the market during the forecast period.
- Published: June 2023
- Price: $ 4950
- TOC Available:
Records 1 to 10 of 50
